Brii Biosciences Ltd
HKEX:2137
Brii Biosciences Ltd
HKEX:2137
Price:
1.25 HKD
-2.34%
Updated:
May 8, 2024
Income Statement
Earnings Waterfall
Brii Biosciences Ltd
Brii Biosciences Ltd
|
Revenue
|
617k
CNY
|
|
Operating Expenses
|
-184.5m
CNY
|
|
Operating Income
|
-183.9m
CNY
|
|
Other Expenses
|
9m
CNY
|
|
Net Income
|
-174.8m
CNY
|
Income Statement
Brii Biosciences Ltd
Brii Biosciences Ltd
Currency: CNY
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Revenue |
0
N/A
|
0
N/A
|
52
N/A
|
52
+1%
|
1
-99%
|
|
| Operating Income | ||||||
| Operating Expenses |
(4 209)
|
(1 591)
|
(560)
|
(458)
|
(184)
|
|
| Selling, General & Administrative |
(208)
|
(251)
|
(195)
|
(189)
|
(198)
|
|
| Research & Development |
(492)
|
(593)
|
(438)
|
(381)
|
(401)
|
|
| Depreciation & Amortization |
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
|
| Other Operating Expenses |
(3 506)
|
(744)
|
76
|
115
|
416
|
|
| Operating Income |
(4 209)
N/A
|
(1 591)
+62%
|
(508)
+68%
|
(406)
+20%
|
(184)
+55%
|
|
| Pre-Tax Income | ||||||
| Interest Income Expense |
50
|
(2)
|
19
|
91
|
(0)
|
|
| Non-Reccuring Items |
(32)
|
(10)
|
0
|
(5)
|
0
|
|
| Pre-Tax Income |
(4 191)
N/A
|
(1 603)
+62%
|
(490)
+69%
|
(321)
+34%
|
(184)
+43%
|
|
| Net Income | ||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(4 191)
|
(1 603)
|
(490)
|
(321)
|
(184)
|
|
| Income to Minority Interest |
27
|
45
|
5
|
(6)
|
10
|
|
| Net Income (Common) |
(4 164)
N/A
|
(1 558)
+63%
|
(484)
+69%
|
(327)
+33%
|
(175)
+46%
|
|
| EPS (Diluted) |
-9.48
N/A
|
-2.15
+77%
|
-0.67
+69%
|
-0.45
+33%
|
-0.24
+47%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
